Table 1. Clinical Next Generation Sequencing (NGS) Market Size & CAGR: China VS Global, (US$ Million), 2019-2030

Table 2. Clinical Next Generation Sequencing (NGS) Market Restraints

Table 3. Clinical Next Generation Sequencing (NGS) Market Trends

Table 4. Clinical Next Generation Sequencing (NGS) Industry Policy

Table 5. Global Clinical Next Generation Sequencing (NGS) Revenue by Company (2019-2024) & (US$ million)

Table 6. Global Clinical Next Generation Sequencing (NGS) Revenue Market Share by Company (2019-2024)

Table 7. Global Clinical Next Generation Sequencing (NGS) Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 8. Global Clinical Next Generation Sequencing (NGS) Mergers & Acquisitions, Expansion Plans

Table 9. Global Clinical Next Generation Sequencing (NGS) Manufacturers Product Type

Table 10. China Clinical Next Generation Sequencing (NGS) Revenue by Company (2019-2024) & (US$ million)

Table 11. China Clinical Next Generation Sequencing (NGS) Revenue Market Share by Company (2019-2024)

Table 12. Global Key Players of Clinical Next Generation Sequencing (NGS) Upstream (Raw Materials)

Table 13. Global Clinical Next Generation Sequencing (NGS) Typical Customers

Table 14. Clinical Next Generation Sequencing (NGS) Typical Distributors

Table 15. By Type, Global Clinical Next Generation Sequencing (NGS) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 16. By Application, Global Clinical Next Generation Sequencing (NGS) Revenue & CAGR, 2019 VS 2024 VS 2030, US$ Million

Table 17. By Region, Global Clinical Next Generation Sequencing (NGS) Market Size, 2019 VS 2024 VS 2030, US$ Million

Table 18. By Region, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Table 19. By Country, Global Clinical Next Generation Sequencing (NGS) Revenue & CAGR，2019 VS 2024 VS 2030, US$ Million

Table 20. By Country, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Table 21. By Country, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Table 22. Agilent Technologies Company Information, Head Office, Market Area and Industry Position

Table 23. Agilent Technologies Company Profile and Main Business

Table 24. Agilent Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 25. Agilent Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 26. Agilent Technologies Recent Developments

Table 27. Illumina Company Information, Head Office, Market Area and Industry Position

Table 28. Illumina Company Profile and Main Business

Table 29. Illumina Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 30. Illumina Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 31. Illumina Recent Developments

Table 32. Thermo Fisher Scientific Company Information, Head Office, Market Area and Industry Position

Table 33. Thermo Fisher Scientific Company Profile and Main Business

Table 34. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 35. Thermo Fisher Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 36. Thermo Fisher Scientific Recent Developments

Table 37. Eurofins Scientific Company Information, Head Office, Market Area and Industry Position

Table 38. Eurofins Scientific Company Profile and Main Business

Table 39. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 40. Eurofins Scientific Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 41. Eurofins Scientific Recent Developments

Table 42. BGI Group Company Information, Head Office, Market Area and Industry Position

Table 43. BGI Group Company Profile and Main Business

Table 44. BGI Group Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 45. BGI Group Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 46. BGI Group Recent Developments

Table 47. Qiagen Company Information, Head Office, Market Area and Industry Position

Table 48. Qiagen Company Profile and Main Business

Table 49. Qiagen Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 50. Qiagen Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 51. Qiagen Recent Developments

Table 52. Roche Diagnostics Company Information, Head Office, Market Area and Industry Position

Table 53. Roche Diagnostics Company Profile and Main Business

Table 54. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 55. Roche Diagnostics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 56. Roche Diagnostics Recent Developments

Table 57. Bio-Rad Company Information, Head Office, Market Area and Industry Position

Table 58. Bio-Rad Company Profile and Main Business

Table 59. Bio-Rad Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 60. Bio-Rad Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 61. Bio-Rad Recent Developments

Table 62. Congenica Company Information, Head Office, Market Area and Industry Position

Table 63. Congenica Company Profile and Main Business

Table 64. Congenica Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 65. Congenica Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 66. Congenica Recent Developments

Table 67. Theragen Etex Company Information, Head Office, Market Area and Industry Position

Table 68. Theragen Etex Company Profile and Main Business

Table 69. Theragen Etex Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 70. Theragen Etex Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 71. Theragen Etex Recent Developments

Table 72. PerkinElmer Company Information, Head Office, Market Area and Industry Position

Table 73. PerkinElmer Company Profile and Main Business

Table 74. PerkinElmer Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 75. PerkinElmer Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 76. PerkinElmer Recent Developments

Table 77. Partek Company Information, Head Office, Market Area and Industry Position

Table 78. Partek Company Profile and Main Business

Table 79. Partek Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 80. Partek Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 81. Partek Recent Developments

Table 82. Oxford Nanopore Technologies Company Information, Head Office, Market Area and Industry Position

Table 83. Oxford Nanopore Technologies Company Profile and Main Business

Table 84. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 85. Oxford Nanopore Technologies Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 86. Oxford Nanopore Technologies Recent Developments

Table 87. Pacific Biosciences of California Company Information, Head Office, Market Area and Industry Position

Table 88. Pacific Biosciences of California Company Profile and Main Business

Table 89. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 90. Pacific Biosciences of California Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 91. Pacific Biosciences of California Recent Developments

Table 92. Golden Helix Company Information, Head Office, Market Area and Industry Position

Table 93. Golden Helix Company Profile and Main Business

Table 94. Golden Helix Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 95. Golden Helix Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 96. Golden Helix Recent Developments

Table 97. BioDatomics Company Information, Head Office, Market Area and Industry Position

Table 98. BioDatomics Company Profile and Main Business

Table 99. BioDatomics Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 100. BioDatomics Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 101. BioDatomics Recent Developments

Table 102. PierianDx Company Information, Head Office, Market Area and Industry Position

Table 103. PierianDx Company Profile and Main Business

Table 104. PierianDx Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 105. PierianDx Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 106. PierianDx Recent Developments

Table 107. DNAStar Company Information, Head Office, Market Area and Industry Position

Table 108. DNAStar Company Profile and Main Business

Table 109. DNAStar Clinical Next Generation Sequencing (NGS) Models, Specifications and Application

Table 110. DNAStar Clinical Next Generation Sequencing (NGS) Revenue and Gross Margin, 2019-2024

Table 111. DNAStar Recent Developments

List of Figure

Figure 1. Clinical Next Generation Sequencing (NGS) Picture

Figure 2. Global Clinical Next Generation Sequencing (NGS) Industry Market Size and Forecast (US$ million) & (2019-2030)

Figure 3. China Clinical Next Generation Sequencing (NGS) Revenue and Forecast (US$ million) & (2019-2030)

Figure 4. 2019-2030 China Clinical Next Generation Sequencing (NGS) Market Share of Global

Figure 5. Global Clinical Next Generation Sequencing (NGS) Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 6. Global Clinical Next Generation Sequencing (NGS) Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2019-2024

Figure 7. China Clinical Next Generation Sequencing (NGS) Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 8. China Clinical Next Generation Sequencing (NGS) Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2024

Figure 9. Clinical Next Generation Sequencing (NGS) Industry Chain

Figure 10. Sequencing by Synthesis (SBS)

Figure 11. Nanopore Sequencing

Figure 12. Single-Molecule Real-Time (SMRT) Sequencing

Figure 13. Others

Figure 14. By Type, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Figure 15. By Type, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Figure 16. Diagnostics

Figure 17. Drug Discovery & Designing

Figure 18. Medical Research

Figure 19. Others

Figure 20. By Application, Global Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, US$ Million

Figure 21. By Application, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Figure 22. By Region, Global Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2030

Figure 23. North America Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 24. By Country, North America Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 25. Europe Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 26. By Country, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 27. Asia Pacific Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 28. By Country/Region, Asia Pacific Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 29. South America Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 30. By Country, South America Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2019-2024

Figure 31. Middle East & Africa Clinical Next Generation Sequencing (NGS) Revenue & Forecasts, 2019-2030, US$ Million

Figure 32. U.S. Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 33. By Company, U.S. Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 34. By Type, U.S. Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 35. By Application, U.S. Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 36. Europe Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 37. By Company, Europe Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 38. By Type, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 39. By Application, Europe Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 40. China Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 41. By Company, China Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 42. By Type, China Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 43. By Application, China Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 44. Japan Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 45. By Company, Japan Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 46. By Type, Japan Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 47. By Application, Japan Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 48. South Korea Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 49. By Company, South Korea Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 50. By Type, South Korea Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 51. By Application, South Korea Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 52. Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 53. By Company, Southeast Asia Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 54. By Type, Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 55. By Application, Southeast Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 56. India Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 57. By Company, India Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 58. By Type, India Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 59. By Application, India Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 60. Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue, 2019-2030, (US$ Million)

Figure 61. By Company, Middle East & Asia Clinical Next Generation Sequencing (NGS) Market Share, 2019-2024

Figure 62. By Type, Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 63. By Application, Middle East & Asia Clinical Next Generation Sequencing (NGS) Revenue Market Share, 2023 VS 2029

Figure 64. Research Methodology

Figure 65. Breakdown of Primary Interviews

Figure 66. Bottom-up Approaches

Figure 67. Top-down Approaches